APA

Stennicke H. R., Kjalke M., Karpf D. M., Balling K. W., Johansen P. B., Elm T., Øvlisen K., Möller F., Holmberg H. L., Gudme C. N., Persson E., Hilden I., Pelzer H., Rahbek-Nielsen H., Jespersgaard C., Bogsnes A., Pedersen A. A., Kristensen A. K., Peschke B., Kappers W., Rode F., Thim L., Tranholm M., Ezban M., Olsen E. H. N. & Bjørn S. E. (20130513). A novel B-domain O-glycoPEGylated FVIII (N8-GP) demonstrates full efficacy and prolonged effect in hemophilic mice models. : Blood.

Chicago

Stennicke Henning R, Kjalke Marianne, Karpf Ditte M, Balling Kristoffer W, Johansen Peter B, Elm Torben, Øvlisen Kristine, Möller Flemming, Holmberg Heidi L, Gudme Charlotte N, Persson Egon, Hilden Ida, Pelzer Hermann, Rahbek-Nielsen Henrik, Jespersgaard Christina, Bogsnes Are, Pedersen Anette A, Kristensen Anne K, Peschke Bernd, Kappers Wendy, Rode Frederik, Thim Lars, Tranholm Mikael, Ezban Mirella, Olsen Eva H N and Bjørn Søren E. 20130513. A novel B-domain O-glycoPEGylated FVIII (N8-GP) demonstrates full efficacy and prolonged effect in hemophilic mice models. : Blood.

Harvard

Stennicke H. R., Kjalke M., Karpf D. M., Balling K. W., Johansen P. B., Elm T., Øvlisen K., Möller F., Holmberg H. L., Gudme C. N., Persson E., Hilden I., Pelzer H., Rahbek-Nielsen H., Jespersgaard C., Bogsnes A., Pedersen A. A., Kristensen A. K., Peschke B., Kappers W., Rode F., Thim L., Tranholm M., Ezban M., Olsen E. H. N. and Bjørn S. E. (20130513). A novel B-domain O-glycoPEGylated FVIII (N8-GP) demonstrates full efficacy and prolonged effect in hemophilic mice models. : Blood.

MLA

Stennicke Henning R, Kjalke Marianne, Karpf Ditte M, Balling Kristoffer W, Johansen Peter B, Elm Torben, Øvlisen Kristine, Möller Flemming, Holmberg Heidi L, Gudme Charlotte N, Persson Egon, Hilden Ida, Pelzer Hermann, Rahbek-Nielsen Henrik, Jespersgaard Christina, Bogsnes Are, Pedersen Anette A, Kristensen Anne K, Peschke Bernd, Kappers Wendy, Rode Frederik, Thim Lars, Tranholm Mikael, Ezban Mirella, Olsen Eva H N and Bjørn Søren E. A novel B-domain O-glycoPEGylated FVIII (N8-GP) demonstrates full efficacy and prolonged effect in hemophilic mice models. : Blood. 20130513.